Literature DB >> 18406591

Emerging concepts in CD8(+) T regulatory cells.

Jerry Y Niederkorn1.   

Abstract

CD8(+) T regulatory cells (T regs) are elicited by unique antigen presenting cells during viral infections, by manipulation of co-stimulatory molecules, or in the development of tumors. CD8(+) T regs display antigen-specificity, which is most exquisitely manifested by the HLA-E-restricted cytolytic CD8(+) T regs in MS. There is evidence that some CD8(+) T regs also express organ specificity. In many cases, IFN-gamma is required for either the induction or expression of CD8(+) T regs. CD8(+) T regs can produce suppression directly by killing immune cells or indirectly by co-opting other cells to elaborate end-stage suppressive molecules such as TGF-beta, IL-10, and indoleamine dioxygenase (IDO).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406591      PMCID: PMC2525788          DOI: 10.1016/j.coi.2008.02.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  37 in total

1.  NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance.

Authors:  K H Sonoda; D E Faunce; M Taniguchi; M Exley; S Balk; J Stein-Streilein
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance.

Authors:  Douglas E Faunce; Joan Stein-Streilein
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

3.  CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site.

Authors:  Takahiko Nakamura; Koh-Hei Sonoda; Douglas E Faunce; Jenny Gumperz; Takashi Yamamura; Sachiko Miyake; Joan Stein-Streilein
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

4.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

5.  gammadelta T cells are critical for the induction of anterior chamber-associated immune deviation.

Authors:  Y Xu; J A Kapp
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

6.  Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.

Authors:  M E Skelsey; J Mellon; J Y Niederkorn
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.

Authors:  Nitin J Karandikar; Michael P Crawford; Xiao Yan; Robert B Ratts; Jason M Brenchley; David R Ambrozak; Amy E Lovett-Racke; Elliot M Frohman; Peter Stastny; Daniel C Douek; Richard A Koup; Michael K Racke
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

8.  CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.

Authors:  Molly E Skelsey; Elizabeth Mayhew; Jerry Y Niederkorn
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

9.  Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.

Authors:  Scott J Roberts; Bernice Y Ng; Renata B Filler; Julia Lewis; Earl J Glusac; Adrian C Hayday; Robert E Tigelaar; Michael Girardi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

10.  Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.

Authors:  Howard F Tiano; Charles D Loftin; Jackie Akunda; Christopher A Lee; Judson Spalding; Alisha Sessoms; David B Dunson; Eleanor G Rogan; Scott G Morham; Robert C Smart; Robert Langenbach
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  31 in total

1.  sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

Authors:  Yi Wei; Seth P Epstein; Shima Fukuoka; Neil P Birmingham; Xiu-Min Li; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

2.  Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Authors:  Maria Papatriantafyllou; Gerhard Moldenhauer; Julia Ludwig; Anna Tafuri; Natalio Garbi; Gorana Hollmann; Günter Küblbeck; Alexandra Klevenz; Sabine Schmitt; Georg Pougialis; Christof Niehrs; Hermann-Josef Gröne; Gunter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  A Fox of a different color: FoxA1 programs a new regulatory T cell subset.

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  Nat Med       Date:  2014-03       Impact factor: 53.440

4.  Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.

Authors:  Elena V Shashkova; Jahnavi Trivedi; Anna B Cline-Smith; Chloe Ferris; Zachary S Buchwald; Jesse Gibbs; Deborah Novack; Rajeev Aurora
Journal:  J Immunol       Date:  2016-06-20       Impact factor: 5.422

5.  Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes.

Authors:  Pierre L Triozzi; Lynn Schoenfield; Thomas Plesec; Yogen Saunthararajah; Raymond R Tubbs; Arun D Singh
Journal:  Oncoimmunology       Date:  2014-10-31       Impact factor: 8.110

6.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

Review 7.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

8.  IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.

Authors:  Magdalena Huber; Sylvia Heink; Axel Pagenstecher; Katharina Reinhard; Josephine Ritter; Alexander Visekruna; Anna Guralnik; Nadine Bollig; Katharina Jeltsch; Christina Heinemann; Eva Wittmann; Thorsten Buch; Olivia Prazeres da Costa; Anne Brüstle; Dirk Brenner; Tak W Mak; Hans-Willi Mittrücker; Björn Tackenberg; Thomas Kamradt; Michael Lohoff
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

9.  Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2.

Authors:  Emna Dabbeche-Bouricha; Luiza M Araujo; Masashi Kato; Armelle Prévost-Blondel; Henri-Jean Garchon
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

Review 10.  Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Mehdi Yousefi; Mina Hajifaraj Tabrizi; Fazel Shokri
Journal:  Tumour Biol       Date:  2013-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.